Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel
Asia-Pacific Psychiatry · 2023
DOI: 10.1111/appy.12550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Psychiatry, 2023. Verfasst von Nicollette L R Thornton und 12 weiteren Autor:innen. Beteiligte Einrichtung: Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen-Cilag Pty Ltd.
Abstract (Originalsprache)
Background
Major depressive disorder (MDD) can have severe impacts on function and quality of life. Up to one third of patients will have an inadequate response to their first line of treatment, with subsequent lines of therapy associated with lower remission rates and higher relapse rates. Recently esketamine has become available for Australian patients, and this agent provides an additional treatment option for those with MDD who have had an inadequate response to two or more antidepressant therapies during the current moderate to severe depressive episode. This paper provides an expert panel's practical recommendations and clinical guidance for establishing esketamine clinics in Australia.
Methods
An expert panel ( n = 11) comprising psychiatrists, mental health care nurses, pharmacists, and individuals with experience establishing esketamine clinics was convened in Sydney. The panel developed practical recommendations and clinical guidance, which were then further refined.
Results
Five key areas were identified: practical considerations for esketamine clinic set‐up, including multidisciplinary care considerations; patient selection; administering esketamine; adverse event management and long‐term follow‐up.
Conclusions
Guidance presented in this paper should assist Australian clinicians to set up an esketamine clinic, and provide practical advice on the infrastructure and clinical requirements for treatment of patients with this agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Older Persons Mental Health Service, Rural and Remote Mental Health Services, South Australia, Australia.
- Greenslopes Clinic, Queensland, Australia.
- Greenslopes Private Hospital, Brisbane, Queensland, Australia.
- Monarch Mental Health Group, New South Wales, Australia.
- Perth Clinic, Western Australia, Australia.
ORCID-Profile: Nicollette L R Thornton, Warwick Black, Adrian Bognar, Daniel Dagge, Teresia Gitau, Bruce Hua, Gero Joks, Jarrad King, Andrew Lord, Elizabeth M Scott, Jelena Smit Callander, Serena Ting, Dennis Liu
Förderung
- Janssen-Cilag Pty Ltd
Zitieren
APA
Thornton, N. L. R., Black, W., Bognar, A., Dagge, D., Gitau, T., Hua, B., Joks, G., King, J., Lord, A., Scott, E. M., Callander, J. S., Ting, S., & Liu, D. (2023). Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel. Asia-Pacific Psychiatry. https://doi.org/10.1111/appy.12550
Vancouver
Thornton NLR, Black W, Bognar A, Dagge D, Gitau T, Hua B, et al. Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel. Asia-Pacific Psychiatry. 2023. doi:10.1111/appy.12550
BibTeX
@article{Thornton2023,
author = {Thornton, Nicollette L R and Black, Warwick and Bognar, Adrian and Dagge, Daniel and Gitau, Teresia and Hua, Bruce and Joks, Gero and King, Jarrad and Lord, Andrew and Scott, Elizabeth M and Callander, Jelena Smit and Ting, Serena and Liu, Dennis},
title = {Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel},
journal = {Asia-Pacific Psychiatry},
year = {2023},
doi = {10.1111/appy.12550}
}
EUVIMED